Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Common Equity (2017 - 2025)

Inspire Medical Systems' Common Equity history spans 9 years, with the latest figure at $781.2 million for Q4 2025.

  • For Q4 2025, Common Equity rose 13.26% year-over-year to $781.2 million; the TTM value through Dec 2025 reached $781.2 million, up 13.26%, while the annual FY2025 figure was $781.2 million, 13.26% up from the prior year.
  • Common Equity for Q4 2025 was $781.2 million at Inspire Medical Systems, up from $666.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $781.2 million in Q4 2025 and bottomed at $219.9 million in Q2 2021.
  • The 5-year median for Common Equity is $536.8 million (2023), against an average of $491.8 million.
  • The largest annual shift saw Common Equity dropped 5.86% in 2021 before it soared 133.21% in 2023.
  • A 5-year view of Common Equity shows it stood at $229.0 million in 2021, then soared by 116.55% to $496.0 million in 2022, then rose by 15.42% to $572.5 million in 2023, then rose by 20.47% to $689.7 million in 2024, then rose by 13.26% to $781.2 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Common Equity are $781.2 million (Q4 2025), $666.5 million (Q3 2025), and $677.8 million (Q2 2025).